Evidence map›Paper›PMID 35337753›Full record

ArticleTransfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis2022

The feasibility of multiple units of convalescent plasma in mechanically ventilated patients with COVID-19: A pilot study.

Noah M Merin, Alexis A LeVee, Christian A Merlo, Kellie Spector, Hannah Coleman, Ellen Klapper, Chelsea Hayes, Rachel Zabner, John F McDyer, Yolanda J Eby and 4 more

Open access · bronzeAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Noah M MerinDepartment of Internal Medicine, Division of Hematology, Cedars-Sinai Medical Center, Los Angeles, USA.
Alexis A LeVeeDepartment of Internal Medicine, Cedars-Sinai Medical Center, Los Angeles, USA.
Christian A MerloDepartment of Internal Medicine, Division of Hematology, Cedars-Sinai Medical Center, Los Angeles, USA; Department of Medicine, Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, USA.
Kellie SpectorDepartment of Internal Medicine, Cedars-Sinai Medical Center, Los Angeles, USA.
Hannah ColemanCedars-Sinai Medical Center, Los Angeles, USA.
Ellen KlapperDepartment of Pathology, Division of Transfusion Medicine, Cedars-Sinai Medical Center, Los Angeles, USA.
Chelsea HayesDepartment of Pathology, Division of Transfusion Medicine, Cedars-Sinai Medical Center, Los Angeles, USA.
Rachel ZabnerDepartment of Medicine, Division of Infectious Diseases, Cedars-Sinai Medical Center, Los Angeles, USA.
John F McDyerDepartment of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh, Pittsburgh, USA.
Yolanda J EbyDepartment of Pathology, Division of Transfusion Medicine, Johns Hopkins University School of Medicine, Baltimore, USA.
David J SullivanDepartment of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.
Aaron A R TobianDepartment of Pathology, Division of Transfusion Medicine, Johns Hopkins University School of Medicine, Baltimore, USA.
Evan M BlochDepartment of Pathology, Division of Transfusion Medicine, Johns Hopkins University School of Medicine, Baltimore, USA.
David N HagerDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, USA. Electronic address: dhager1@jhmi.edu.
Cedars-Sinai Medical Center · USJohns Hopkins Medicine · USJohns Hopkins University · USUniversity of Pittsburgh · US

Funding

Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2U54CA260591 · NCI · CEDARS-SINAI MEDICAL CENTER · PI FIGUEIREDO, JANE C., KARIN, MICHAEL · 2020 to 2024
$9.1M
Conjugate vaccines for prevention and treatment of cryptococcosis - COVID-19 Revision SupplementR01AI152078 · NIAID · JOHNS HOPKINS UNIVERSITY · PI CASADEVALL, ARTURO · 2020 to 2024
$5.1M
The Malaria Transfusion Risk (MATRix) StudyK23HL151826 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI BLOCH, EVAN MARTIN · 2020 to 2024
$882k
NCI NIH HHS U54 CA260591NHLBI NIH HHS K23 HL151826NIAID NIH HHS R01 AI152078
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Antibodies, ViralCOVID-19 SerotherapyFeasibility StudiesHumansImmunization, PassivePilot ProjectsRespiration, ArtificialAntibodies, ViralAnti-SARS-CoV-2 plasmaConvalescent plasmaCOVID-19Pandemic

Identifiers

PMID35337753
PMCPMC8923025
OpenAlexW4220954337

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.